Streetbeat News

Stock Prices

PET

Wag! Group shares are trading lower following the announcement of an underwritten public offering of 7,407,407 shares of its common stock at $1.35 per share.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:09 pm

ASLN

ASLAN Pharmaceuticals shares are trading lower following the announcement that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:07 pm

AAPL

AMD

ASML

NVDA

TSM

Shares of Taiwan Semiconductor Manufacturing Company Limited (TSMC) fell sharply in premarket trading due to comments by Donald Trump regarding the China-Taiwan standoff and a lukewarm forecast by ASML Holding N.V. TSMC supplies chips to major tech companies like Nvidia, Apple, and AMD.

Portfolio Pulse from Shanthi Rexaline

July 17, 2024 | 12:07 pm

FAAS

LPLA

SCHW

The article highlights three oversold financial stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are Charles Schwab Corporation (SCHW), DigiAsia Corp (FAAS), and LPL Financial Holdings Inc (LPLA).

Portfolio Pulse from Avi Kapoor

July 17, 2024 | 12:06 pm

BLND

CYAN

TKNO

Insiders are aggressively buying shares in Alpha Teknova, Cyanotech, and Blend Labs. Significant insider transactions include a $15 million purchase in Alpha Teknova, a $5,400 purchase in Cyanotech, and a $16,940 purchase in Blend Labs. These transactions may indicate confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

July 17, 2024 | 12:06 pm

BB

BlackBerry Limited (NYSE:BB) has launched CylanceMDR Pro, an AI-powered managed detection and response (MDR) service aimed at enhancing cybersecurity for businesses. Despite this launch, BB shares are trading marginally lower in the premarket session. The stock has slumped over 47% in the past year but has an average 1-year price target of $3.36, representing an expected upside of 31.25%.

Portfolio Pulse from Nabaparna Bhattacharya

July 17, 2024 | 12:05 pm

LGVN

Longeveron shares are trading higher after the company announced that the FDA granted Fast Track designation to Lomecel-B for the treatment of mild Alzheimer's Disease.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:05 pm

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) is set to file an NDA for Tonmya for fibromyalgia management in 2H 2024, with potential FDA approval in 2H 2025. This could mark the first new FDA-approved fibromyalgia drug in over 15 years, potentially sparking a market rivalry.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:04 pm

PGR

Analysts have provided mixed ratings for Progressive (NYSE:PGR) over the past three months, with a recent increase in the average 12-month price target to $253.0. The company's financial performance shows strong revenue growth and return on equity, but challenges in net margin and debt management.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:02 pm

RLAY

Relay Therapeutics (NASDAQ:RLAY) has been analyzed by 5 analysts, showing a range of sentiments from bullish to somewhat bullish. The average 12-month price target has decreased by 8.93% to $20.4. Analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Despite significant revenue growth, the company faces challenges with ROE and ROA below industry standards.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm